Dr. Christopher G. Chow, MD

Dr. Chow practices at Christopher G. Chow, MD in Northridge, California.

Dr. Chow's NPI, 1528024122, was assigned on April 22, 2006. Dr. Chow graduated from New York Medical College in 1999. Dr. Chow holds California license A73605.

Dr. Chow's primary practice is Christopher G. Chow, MD, at 18433 Roscoe Blvd, Northridge, CA 91325-4108. The practice phone is (818) 341-4401.

Dr. Chow's primary practice is Christopher G. Chow, MD in Northridge, California. Dr. Chow is also affiliated with Dignity Health - Northridge Hospital Medical Center. The medical group on file is Valley Vascular Partners. Dmand AI also links Dr. Chow to 1 more hospital, 3 home health agencies and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chow practices, 7 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Chow's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Chow is board certified in internal medicine by the American Board of Internal Medicine. Dr. Chow is licensed in California.

Dmand AI lists acid reflux, acute gastroduodenitis, acute skin infection, aneurysm, arthritis, asthma, atrial fibrillation and flutter and bipolar disorder among the conditions Dr. Chow treats.

CMS data shows 2,777 Medicare services from Dr. Chow across 19 procedure codes in 2024, for 464 Medicare patients. Medicare paid $193,860 for them. Every service was in an office.

CMS counts 464 Medicare patients who saw Dr. Chow in 2024. The largest group is 65 to 74, with 209 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 1.10, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Chow's median patient age at 72, with 53% women.

In 2024, Dr. Chow wrote 7,933 Medicare Part D claims for 603 patients. 86% of them were for generic drugs. CMS names the drug for 7,039 of them, across 133 drugs with 11 or more claims each, at $581,763 in total drug cost. In 2023, CMS named 6,439 claims across 123 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Chow for performance year 2024, reported individually. Dr. Chow accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Chow as offering telehealth.

Dmand AI links Dr. Chow to 11 clinical trials. 3 are still active or recruiting. Conditions studied include Diabetes Mellitus, Type 2, Diabetes Mellitus and Obesity. Eli Lilly and Company sponsors the most, 11. Open Payments lists research payments to Dr. Chow that name 14 trials.

CMS Open Payments shows 1,065 general payments to Dr. Chow from 61 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 91% of the total. Eli Lilly and Company paid the most, $3,701. It also lists 23 research payments totaling $198,617 from 2017 to 2024, naming 14 clinical trials.

Dmand AI lists 1 award for Dr. Chow, most recently CMS Stage 1 EHR in 2013.

Dr. Chow graduated from New York Medical College in 1999.

Dr. Chow is in network with 12 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.